Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy

被引:34
|
作者
Lionetti, Vincenzo [1 ,2 ]
Matteucci, Marco [1 ]
Ribezzo, Marco [3 ]
Di Silvestre, Dario [4 ]
Brambilla, Francesca [4 ]
Agostini, Silvia [1 ]
Mauri, Pierluigi [4 ]
Padeletti, Luigi [5 ]
Pingitore, Alessandro [6 ]
Delsedime, Luisa [7 ]
Rinaldi, Mauro [3 ]
Recchia, Fabio A. [1 ,8 ]
Pucci, Angela [9 ]
机构
[1] Scuola Super Sant Anna, Inst Life Sci, Lab Med Sci, I-56124 Pisa, Italy
[2] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy
[3] San Giovanni Battista Univ Hosp, Dept Cardiac Surg, Turin, Italy
[4] CNR, Inst Biomed Technol ITB, I-20133 Milan, Italy
[5] Univ Florence, Dept Med & Surg Crit Care, Florence, Italy
[6] CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[7] S Giovanni Battista Univ Hosp, Dept Histopathol, Turin, Italy
[8] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA
[9] Univ Hosp Pisa, Dept Pathol, Pisa, Italy
关键词
pathologic features; hibernating myocardium; chronic heart failure; idiopathic dilated cardiomyopathy; ischaemic microenvironment; nestin; POSITRON-EMISSION-TOMOGRAPHY; HEART-FAILURE; CONTRACTILE DYSFUNCTION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CORONARY FLOW; RESERVE; ISCHEMIA; DEGRADATION; MECHANISMS;
D O I
10.1111/jcmm.12198
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Myocardial hibernation (MH) is a well-known feature of human ischaemic cardiomyopathy (ICM), whereas its presence in human idiopathic dilated cardiomyopathy (DCM) is still controversial. We investigated the histological and molecular features of MH in left ventricle (LV) regions of failing DCM or ICM hearts. We examined failing hearts from DCM (n=11; 41.9 +/- 5.45years; left ventricle-ejection fraction (LV-EF), 18 +/- 3.16%) and ICM patients (n=12; 58.08 +/- 1.7years; LVEF, 21.5 +/- 6.08%) undergoing cardiac transplantation, and normal donor hearts (N, n=8). LV inter-ventricular septum (IVS) and antero-lateral free wall (FW) were transmurally (i.e. sub-epicardial, mesocardial and sub-endocardial layers) analysed. LV glycogen content was shown to be increased in both DCM and ICM as compared with N hearts (P<0.001), with a U-shaped transmural distribution (lower values in mesocardium). Capillary density was homogenously reduced in both DCM and ICM as compared with N (P<0.05 versus N), with a lower decrease independent of the extent of fibrosis in sub-endocardial and sub-epicardial layers of DCM as compared with ICM. HIF1- and nestin, recognized ischaemic molecular hallmarks, were similarly expressed in DCM-LV and ICM-LV myocardium. The proteomic profile was overlapping by similar to 50% in DCM and ICM groups. Morphological and molecular features of MH were detected in end-stage ICM as well as in end-stage DCM LV, despite epicardial coronary artery patency and lower fibrosis in DCM hearts. Unravelling the presence of MH in the absence of coronary stenosis may be helpful to design a novel approach in the clinical management of DCM.
引用
收藏
页码:396 / 414
页数:19
相关论文
共 50 条
  • [41] Genotype influences end-stage heart failure occurrence in dilated cardiomyopathy
    Cannie, D.
    Bakalakos, A.
    Protonotarios, A.
    Syrris, P.
    Lorenzini, M.
    Guttmann, O.
    O'mahony, C.
    Savvatis, K.
    Lopes, L.
    Sekhri, N.
    Mohiddin, S.
    Elliott, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [42] Partial Left Ventriculectomy for End-Stage Dilated Cardiomyopathy in Small Children
    Kubota, Suguru
    Matsui, Yoshiro
    CIRCULATION JOURNAL, 2009, 73 (06) : 1010 - 1011
  • [43] DISCREPANCY BETWEEN PRETRANSPLANT AND POSTTRANSPLANT DIAGNOSIS OF END-STAGE DILATED CARDIOMYOPATHY
    BORTMAN, G
    SELLANES, M
    ODELL, DS
    RING, WS
    OLIVARI, MT
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (09): : 921 - 924
  • [44] Transcriptome profiling of natriuretic peptide system in cardiac tissue of patients with idiopathic or ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Cesare, M. M.
    Botta, L.
    Caselli, C.
    Matteucci, M.
    Lionetti, V.
    Del Ry, S.
    EUROPEAN HEART JOURNAL, 2015, 36 : 153 - 153
  • [45] Reverse left ventricular remodeling by dobutamine and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy
    Maroulidis, G
    Alexopoulos, G
    Ntalianis, A
    Drakos, S
    Venetsanakos, J
    Christodoulou, K
    Kopelia, M
    Sarafoglou, S
    Savvari, V
    Anastasiou-Nana, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S158 - S158
  • [46] The apelin/APJ mRNA profile in left ventricular tissue of patients with idiopathic or ischemic end-stage dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Botta, L.
    Cesare, M. M.
    Caselli, C.
    Matteucci, M.
    Lionetti, V.
    Del Ry, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 532 - 532
  • [47] Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes
    Yung, CK
    Halperin, VL
    Tomaselli, GF
    Winslow, RL
    GENOMICS, 2004, 83 (02) : 281 - 297
  • [48] HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy
    Harcombe, AA
    Sharples, L
    Large, SR
    Wallwork, J
    Weissberg, PL
    Joysey, V
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 68 (01) : 31 - 37
  • [49] Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy
    Rochette, Luc
    Tatou, Etienne
    Vergely, Catherine
    Maupoil, Veronique
    Bouchot, Olivier
    Mossiat, Claude
    Jazayeri, Sahed
    Benkhadra, Salima
    Brenot, Roger
    Girard, Claude
    David, Michel
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (07): : 767 - 774
  • [50] Regional myocardial flow-metabolism relationship in patients with idiopathic dilated cardiomyopathy
    Neglia, D
    Marini, C
    Toschi, E
    Sorace, O
    Salvadori, P
    Sambuceti, G
    Parodi, O
    L'Abbate, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 187A - 187A